(NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)

A Professor in Pharmaceutical Chemistry, Roz Anderson joined the University in 1987 and in her 31 year career as a researcher worked on the treatment of Alzheimer's disease, diagnosis of bacterial infections, psoriasis and cancer, but her particular passion was the battle against the rare genetic disorder "Cystinosis". For the last 20 years of her life Roz undertook research to find a better, more efficiently targeted method of delivering cysteamine - which is a toxic and noxious drug used in the management of the rare life limiting genetic disorder Cystinosis. The pre-clinical development of CF10 will provide a GMP-compliant synthetic route, GLP toxicology, toxicokinetic and safety data, a…

Read all of it on Contracts Finder →